IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage

• Status: Completed
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The study will evaluate whether prophylactic oxytocin administered in the third stage of labor via IV infusion results in a lower mean blood loss compared to IM injection.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gynuity Health Projects
• Collaborators: Center for Research and Consultancy in Reproductive Health; Huong Vuong Hospital; MOH Etlik Zubeyde Hanim Women's Health Training and Research Hospital
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• All women who present in active labor for a live birth at the study hospital will be considered for participation in the study

Exclusion Criteria: Women who are:

• Planned or transferred for delivery via Cesarean section

• Not delivering a live birth

• Unable to provide informed consent due to mental impairment, distress during labor or other reason

• Unwilling and/or unable to respond to questionnaires about background characteristics and/or bleeding history.